Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Click Me!

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. Aging Knowl. Environ., 10 October 2001
Vol. 2001, Issue 2, p. or12

OTHER RESOURCES

Parkin and Its Substrates

Christian Haass, and Philipp J. Kahle

http://sageke.sciencemag.org/cgi/content/abstract/sageke;2001/2/or12

Abstract: Science 293, 224-225 (2001).

What causes the selective degeneration of nigrostriatal dopaminergic neurons in the brains of Parkinson's disease patients? A clue comes from new work showing that two proteins implicated in Parkinson's disease, parkin and {alpha}-synuclein, normally interact in healthy neurons. The authors speculate that defective targeting of {alpha}-synuclein for degradation by parkin results in the accumulation of toxic {alpha}-synuclein aggregates that selectively kill dopaminergic neurons.

Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products

Science of Aging Knowledge Environment. ISSN 1539-6150